KPI progress reports

Materiality

KPI

Targets

Note

Results in FY2022

(Cumulative number for 2 years)

Improve resuscitation rates by expanding access to AEDs

Number of AEDs sold in the world

[Target]

Cumulative number of products sold for 3 years worldwide:

Over 350k units

Number of AEDs sold:

219k units

(Rate of progress 62%)

 Japan 101k units

 Overseas 118k units

Utilization rate of AEDs in Japan and the U.S.

[Actual]

Actual utilization rate of AEDs in Japan and the U.S. for 3 years

(No numerical target (follow-up item))

Utilization rate is the rate of out-of-hospital cardiac arrests responded to by laypersons using AEDs (all AEDs, including our products).

Utilization rate:

Japan 4.1% in CY2022

(4.2% in CY2021)

U.S. 10.2% in CY2022

(9.0% in CY2021)

Provide educational opportunities for medical professionals in emerging countries

Promote training in epilepsy diagnosis in Indonesia

[Target]

Start operations at 4 local education centers by the end of FY2023

Start operation:
0 centers
Conducted the 6_{th}lectures consisting of a total of 23 lectures. Continue discussions to educate 4 physicians.

Number of educational seminars held, hosting countries, participants (including online programs)

[Target]

  • Cumulative number of hosting countries for 3 years:
    Over 5 countries (North America, Latin America, Europe, Asia, Middle East)
  • Cumulative number of participants for 3 years:
    Over 100k

  • Number of hosting countries:
    7 countries
    (Rate of progress 100%)
  • Number of participants:
    86k
    (Rate of progress 86%)

Automatic control of medical equipment

R&D investment in a robotic anesthesia system

(*)

R&D investment in closed loop control of ventilators

(*)

Develop and provide sensors which are gentle on the patient

R&D investment in new sensors

(*)

Number of products sold that have esCCO~{*1}, synECi18~{*2}, and iNIBP~{*3} installed

[Target]

Cumulative number of products sales for 3 years worldwide:

Over 85k units

Number of products sold:

64k units

(Rate of progress 75%)

Japan 28k units

Overseas 36k units

Create a peaceful patient environment with advanced alarm technology

R&D investment in improved alarm algorithms for patient monitors

(*)

Number of hospitals that utilize Alarm reports~{*4} for improving workflow in Japan and the U.S.

[Target]

Cumulative number of new contract hospitals for 3 years:

Japan Over 240 hospitals

U.S. Over 25 hospitals

Number of new contract hospitals:

Japan 263 hospitals

(Rate of progress 100%)

U.S. 2 hospitals

(Rate of progress 8%)

Contribute to care for patients with heart failure, brain disorders and infection

R&D investment in early warning scores

(*)

R&D investment in new parameters and algorithms for heart failure care

(*)

Improve product utilization rate by remote monitoring

Number of MD Linkage~{*5} sold and number of connected models

[Target]

  • Cumulative number of connected models for 3 years worldwide:
    Over 7 models
  • Cumulative number of connected units for 3 years worldwide:
    Over 5k units

 

 

  • Number of connected models:
    6 models
    (Rate of progress 86%)
    (MEK-1301/02/03, MEK-91/9200, NKV-330)
  • Number of newly connected units:
    1,241 units
    (Rate of progress 25%)

 

Number of advance notifications before trouble with products occurs

[Actual]

Actual cumulative number of notifications for 3 years

(No numerical target (follow-up item))

Only in Japan

Number of notifications:

2,659 cases

Eliminate health disparities through telemedicine

Number of network-oriented products sold like LAVITA~{*6}

[Target]

Cumulative number of contract hospitals for 3 years:

Over 600 hospitals

Only in Japan

Number of contract hospitals:

315 hospitals

(Rate of progress 53%)

R&D investment in realization of remote support for ICUs

(*)

Foster a corporate culture of pride in contributing to healthcare

Employee satisfaction

[Target]

FY2021:

Establish operational policy and start survey (Only in Japan)

FY2022:

Publication of survey results and subsequent implementation of ongoing surveys

Improved 1.4 points compared to FY2021

Develop human resources who can succeed globally

[Target]

Cumulative hours of education for 3 years:

Over 45 hours per person

House of education by job level provided by the Phoenix Academy (Human Resources Development Center). This training content will enable new employees and managers to acquire the knowledge and skills required for each level.

Education hours per person:

36.8 hours

(Rate of progress 82%)

Pursue the highest level of quality in the world across the value chain

Net Promoter Scores

[Target]

Japan 

FY2021:

Set up a system and start survey 

FY2022:

1. Conducted a second survey with more detailed and expanded items to be surveyed

2. Maintain and improve scores

 

U.S.

Strive to achieve a 1 point improvement every year

Japan

1. Conducted a second survey with more detailed and expanded items to be surveyed

2. Improved 1.3 points compared to FY2021

U.S.

Improved 12 points compared to FY2021

Number of recalls

[Actual]

Cumulative number of products recalled for 3 years(No numerical target (follow-up item))

We have set and are working on achieving a quality target of “zero recalls for 200 days or more".

8 cases

Ensure strict compliance and strengthen group governance

Establish and strengthen compliance programs of the Group

[Target]

Zero occurrence of serious incidents of non-compliance

1 case

(FY 2021, Japan)

Establish and promote Global Business Management Policy in overseas subsidiaries

[Actual]

Monitoring implementation of Global Business Management Policy by managers of all overseas subsidiaries over the next 3 years

(No numerical target (follow-up item))

Continued implementation of various measures

Strengthen internal control over domestic sales

[Actual]

Introduce system controls for pre-order processes and monitor their application

(No numerical target (follow-up item))

Continued implementation of the global compliance program measures

Realize a carbon-free society

CO_{2} emissions

[Target]

  • FY2023: 15.2% reduction compared to FY2020 per unit of sales (ISO 14001 certified sites, Scope 1, 2)
  • Collect and disclose CO_{2} emissions for the whole group by end of FY2023 (Scope1, 2, 3)

  • CO_{2} emissions:
    38.7% reduction compared to FY2020
  • Collect and disclose CO_{2} emissions:
    Preparing for third-party verification, including system implementation

Number of models and sales ratio of environment-friendly products

[Actual]

  • Number of models in next 3 years(No numerical target (follow-up item))

[Target]

  • Cumulative sales ratio of products for 3 years worldwide:
    Over 20%

  • Number of models:
    75 series
  • Sales ratio of environment-friendly products:
    19.1%

Amount of waste from disposal of products and parts

[Target]

FY2023: 8% reduction of products and parts retirement compared to FY2020

FY2022:

0.7% reduction compared to FY2020

  1. esCCO (estimated Continuous Cardiac Output): Nihon Kohden’s unique technology which can estimate cardiac output continuously and painlessly based on ECG and pulse waves obtained from pulse oximetry. Previously, cardiac output could not be measured without inserting a catheter into the pulmonary artery. But now, with routinely monitored parameters, non-invasive and continuous estimates can be made without pain or strain on the patient.
  2. Synthesized 18-lead ECG: Synthesized 18-lead ECG uses the 12-lead ECG waveforms to mathematically derive the waveforms of the right chest leads (V3R, V4R, V5R) and back (V7, V8, V9).
    The measurement procedure is the same as the standard 12-lead ECG but more information can be obtained. 18-lead synthesized ECG is expected to be useful in detecting right ventricular infarction and posterior infarction.
  3. iNIBP (non-invasive blood pressure measurement algorithm): Nihon Kohden’s unique non-invasive blood pressure measurement algorithm using a linear inflation technology that completes the measurement while the cuff is inflating. This algorithm was developed with the concept of reducing the burden and stress of patients and medical personnel involved in blood pressure measurement as much as possible. Compared to previous measurement methods, it can measure faster and does not apply more pressure than necessary, reducing the burden and stress on the patient.
  4. Alarm report: This is a report that objectively evaluates the type and frequency of alarms based on alarm information from telemetry systems and central monitors. This report is expected to contribute to improving the medical environment by reducing the occurrence of false alarms.
  5. MD Linkage (Medical device remote monitoring system): This is a network system that automatically sends error messages and self-test information generated by medical devices to our server via a remote terminal. By automatically detecting equipment abnormalities and failures and notifying us, we can respond quickly and contribute to reducing product downtime.
  6. LAVITA (Medical and nursing care network system): This is a network system that can easily collect patient vital data, automatically send it to a cloud server, and share information in real time with various people such as medical workers and soclial workers. By collaborating with various medical institutions through LAVITA, it is possible to provide the support needed for comprehensive community care.

 

(*) We have not set individual investment target figure for each KPI, but the cumulative three-year investment target for the whole Nihon Kohden Group is expected to be approximately 20 billion yen.